Pro Share Advisors LLC Alkermes Plc. Transaction History

Pro Share Advisors LLC

  • $39.7 Billion
  • Q3 2024

A detailed history of Pro Share Advisors LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 43,937 shares of ALKS stock, worth $1.29 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
43,937
Previous 36,051 21.87%
Holding current value
$1.29 Million
Previous $868,000 41.59%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$23.01 - $28.55 $181,456 - $225,145
7,886 Added 21.87%
43,937 $1.23 Million
Q2 2024

Aug 13, 2024
SELL
$23.21 - $27.24 $211,698 - $248,456
-9,121 Reduced 20.19%
36,051 $868,000
Q1 2024

May 08, 2024
BUY
$26.4 - $32.56 $88,440 - $109,076
3,350 Added 8.01%
45,172 $1.22 Million
Q4 2023

Feb 14, 2024
BUY
$23.37 - $28.68 $219,117 - $268,903
9,376 Added 28.9%
41,822 $1.16 Million
Q3 2023

Nov 13, 2023
BUY
$27.17 - $31.97 $3,178 - $3,740
117 Added 0.36%
32,446 $908,000
Q2 2023

Aug 10, 2023
BUY
$28.34 - $33.63 $49,339 - $58,549
1,741 Added 5.69%
32,329 $1.01 Million
Q1 2023

May 25, 2023
BUY
$25.31 - $29.02 $774,182 - $887,663
30,588 New
30,588 $862,000
Q4 2022

Feb 02, 2023
BUY
$21.94 - $26.24 $58,272 - $69,693
2,656 Added 7.72%
37,064 $968,000
Q3 2022

Nov 04, 2022
BUY
$22.0 - $31.87 $15,048 - $21,799
684 Added 2.03%
34,408 $768,000
Q2 2022

Aug 01, 2022
SELL
$26.4 - $30.54 $443,916 - $513,530
-16,815 Reduced 33.27%
33,724 $1.01 Million
Q1 2022

May 10, 2022
SELL
$23.07 - $27.99 $261,544 - $317,322
-11,337 Reduced 18.32%
50,539 $1.33 Million
Q4 2021

Feb 08, 2022
BUY
$21.47 - $32.08 $65,182 - $97,394
3,036 Added 5.16%
61,876 $1.44 Million
Q3 2021

Nov 12, 2021
SELL
$23.37 - $32.13 $406,801 - $559,286
-17,407 Reduced 22.83%
58,840 $1.82 Million
Q2 2021

Aug 13, 2021
BUY
$18.78 - $25.15 $961,911 - $1.29 Million
51,220 Added 204.66%
76,247 $1.87 Million
Q1 2021

May 14, 2021
SELL
$18.21 - $23.2 $43,576 - $55,517
-2,393 Reduced 8.73%
25,027 $468,000
Q4 2020

Feb 09, 2021
SELL
$15.39 - $22.1 $14,666 - $21,061
-953 Reduced 3.36%
27,420 $547,000
Q3 2020

Nov 13, 2020
BUY
$16.16 - $20.66 $7,191 - $9,193
445 Added 1.59%
28,373 $470,000
Q2 2020

Aug 03, 2020
BUY
$13.31 - $19.41 $44,734 - $65,237
3,361 Added 13.68%
27,928 $542,000
Q1 2020

May 15, 2020
SELL
$13.06 - $21.24 $173,632 - $282,385
-13,295 Reduced 35.11%
24,567 $354,000
Q4 2019

Feb 12, 2020
SELL
$17.29 - $21.74 $144,630 - $181,855
-8,365 Reduced 18.1%
37,862 $772,000
Q3 2019

Nov 12, 2019
SELL
$19.51 - $24.28 $65,963 - $82,090
-3,381 Reduced 6.82%
46,227 $902,000
Q2 2019

Aug 13, 2019
SELL
$21.47 - $37.33 $207,529 - $360,831
-9,666 Reduced 16.31%
49,608 $1.12 Million
Q1 2019

May 15, 2019
BUY
$28.4 - $36.49 $57,879 - $74,366
2,038 Added 3.56%
59,274 $2.16 Million
Q4 2018

Feb 14, 2019
SELL
$27.94 - $44.61 $323,712 - $516,851
-11,586 Reduced 16.83%
57,236 $1.69 Million
Q3 2018

Nov 14, 2018
SELL
$38.6 - $46.12 $926 - $1,106
-24 Reduced 0.03%
68,822 $2.92 Million
Q2 2018

Aug 13, 2018
SELL
$40.56 - $51.36 $298,156 - $377,547
-7,351 Reduced 9.65%
68,846 $2.83 Million
Q1 2018

May 14, 2018
SELL
$53.61 - $67.26 $578,934 - $726,340
-10,799 Reduced 12.41%
76,197 $4.42 Million
Q4 2017

Feb 14, 2018
SELL
$47.69 - $55.39 $153,132 - $177,857
-3,211 Reduced 3.56%
86,996 $4.76 Million
Q3 2017

Nov 13, 2017
BUY
$49.16 - $54.45 $411,567 - $455,855
8,372 Added 10.23%
90,207 $4.59 Million
Q2 2017

Aug 11, 2017
BUY
N/A
81,835
81,835 $4.74 Million

Others Institutions Holding ALKS

# of Institutions
363
Shares Held
182M
Call Options Held
175K
Put Options Held
96.6K
View Full List

About Alkermes plc.

ALKS Quotes by TradingView
  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.82B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email